Selected article for: "infection status and multivariate analysis"
Author: Sobolewski, Piotr; Antecki, Jacek; Brola, Waldemar; Fudala, Małgorzata; Bieniaszewski, Leszek; Kozera, Grzegorz
Title: Systemic thrombolysis in ischaemic stroke patients with COVID‐19
  • Cord-id: a6hta6ve
  • Document date: 2021_8_20
    • ID: a6hta6ve
    Snippet: OBJECTIVE: Intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator is the core medical therapy of acute ischaemic stroke (AIS). COVID‐19 infection negatively modifies acute stroke procedures and, due to its pro‐coagulative effect, may potentially impact on IVT outcome. Thus, short‐term efficacy and safety of IVT were compared in patients with and without evidence of SARS‐CoV‐2. METHODS: An observational, retrospective study included 70 patients with AIS, including
    Document: OBJECTIVE: Intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator is the core medical therapy of acute ischaemic stroke (AIS). COVID‐19 infection negatively modifies acute stroke procedures and, due to its pro‐coagulative effect, may potentially impact on IVT outcome. Thus, short‐term efficacy and safety of IVT were compared in patients with and without evidence of SARS‐CoV‐2. METHODS: An observational, retrospective study included 70 patients with AIS, including 22 subjects (31%) with evidence of acute COVID‐19 infection, consecutively treated with IVT in 4 stroke centres between 15 September and 30 November 2020. RESULTS: Patients infected with COVID‐19 were characterized by higher median of National Institute of Health Stroke Scale (NIHSS) score (11.0 vs. 6.5; p < .01) and D‐dimers (870 vs. 570; p = .03) on admission, higher presence of pneumonia (47.8% vs. 12%; p < .01) and lower percentage of ‘minor stroke symptoms’ (NIHSS 1–5 pts.) (2% vs., 18%; p < .01). Hospitalizations were longer in patients with COVID‐19 than in those without it (17 vs. 9 days, p < .01), but impact of COVID‐19 infection on patients’ in‐hospital mortality or functional status on dismission has been confirmed neither in uni‐ or multivariate analysis. CONCLUSION: SARS‐CoV‐2 infection prolongs length of stay in hospital after IVT, but does not influence in‐hospital outcome.

    Search related documents:
    Co phrase search for related documents
    • acute ischaemic stroke and logistic regression model: 1, 2
    • acute ischaemic stroke and long term outcome: 1, 2, 3
    • acute ischaemic stroke and lung infection: 1
    • acute ischaemic stroke and magnetic resonance: 1, 2, 3, 4, 5
    • acute stroke and admission score: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute stroke and logistic regression model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • acute stroke and logistic regression model multivariate: 1, 2
    • acute stroke and long term outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute stroke and low percentage: 1
    • acute stroke and low platelet count: 1, 2, 3
    • acute stroke and lung infection: 1, 2
    • acute stroke and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute stroke treatment and admission score: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute stroke treatment and logistic regression model: 1, 2, 3, 4, 5, 6
    • acute stroke treatment and long term outcome: 1, 2, 3, 4, 5
    • acute stroke treatment and low percentage: 1
    • acute stroke treatment and magnetic resonance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • admission score and lung infection: 1, 2, 3
    • admission score and magnetic resonance: 1, 2, 3, 4, 5